Refex Industries Limited (REFEX)
Investor Presentation
Investor Presentation - Q2FY27
- Standalone Q2 revenue ₹560 Cr +36.1% y-y; EBITDA ₹91 Cr +21.7%; PAT ₹60 Cr +13.1%
- H1FY27 revenue ₹1,179 Cr +54.7%; EBITDA ₹196 Cr +71.8%; PAT ₹133 Cr +55.4%
- Ash & Coal business secured new orders worth ₹346 Cr; orderbook ₹1,721 Cr as of Sept 30, 2026
- RGML demerger process to complete in next few months; next NCLT hearing on Oct 28, 2026
- Wind business completed first deliveries to three customers; 5.3 MW turbine manufacturing focus
- Ready Mix Concrete business expanding with phased plant commissioning; asset-light model
- Strong financial position with net debt free balance sheet and FY26 ROCE ~22.0%
- ESG targets: carbon neutral by 2040, water neutral by 2035, extensive ecosystem restoration ongoing
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 REFEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add REFEX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Refex Industries Limited
Important.
The summary above is generated automatically from Refex Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.